uniQure
Entity

  • uniQure

    Created in 1998
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    22,719

  • Activities

    biotech deeptech healthtech

  • Technologies

    Synthetic Biology

  • Entity types

    SMB

  • Location

    Paasheuvelweg 25a, 1105 BP Amsterdam, Netherlands

    Amsterdam

    Netherlands

  • Employees

    Scale: 501-1000

    Estimated: 517

  • Engaged corporates

    2
    2 0

  • Added in Motherbase

    8 months, 1 week ago
Description
  • Value proposition

    Transforming the lives of patients through gene therapy

    uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.

    aav and lpl

  • uniQure | A Global Leader in Gene Therapy

    For more than two decades, we have been working tirelessly to harness the power of genomic medicine to deliver breakthrough treatments that change patients’ lives.

    • https://www.uniqure.com/
Corporate interactions BETA
Corporate TypeTweets Articles
FirstWord Pharma
FirstWord Pharma
Pharmaceutical, Pharmaceutical Manufacturing
FirstWord Pharma
Pharmaceutical, Pharmaceutical Manufacturing 		Other

15 May 2023


SATT Aquitaine Science Transfert
SATT Aquitaine Science Transfert
SATT Aquitaine Science Transfert
Other

6 Feb 2024


Similar entities
Last news
Show all articles
Social network dynamics